Icare When the company set out to find a product development partner, its objective was clear: it wanted to improve the usability of a tonometer (internal eye pressure measurement device) which was on the market. It was also important to ensure the accuracy of the results of measurement made at home. Case Icare Expertise Embedded Systems Icare is an advanced medical technology company The latest product of Icare, the Icare HOME tonometer is designed for self-measurement. It is intended for glaucoma patients who need regular monitoring of intraocular pressure on their doctor’s orders. “We started our cooperation with Etteplan by going through our wishes and preliminary expectations. Ease-of-use and simplicity were at the top of our wish list. In the new Icare HOME tonometer, the user is guided by a light control at the same time as the measurement take places,” says R&D Director Ari Kukkonen from Icare. Etteplan was assigned the responsibility for the software and electronics design of the Icare HOME tonometer as well as system testing. Knowledge was key to success The Icare HOME tonometer’s measurement functions are based on the measurement method of earlier Icare products as well as on patented rebound technology, in which an extremely lightweight sensor touches the cornea of the eye. "In demanding projects, industry knowledge and customer cooperation come to the fore. In this project, a good customer relationship along with a skilled and demanding customer led to an outcome that fulfilled the objectives. For the project’s success, it was essential to understand the medical sector’s standards and quality criteria,” says Etteplan's Project Manager Mikko Kämäräinen. “When the project’s starting points are clear and a common understanding has been established, we can produce a prototype of the device very quickly. Ideally, this means both electronics and software, as in Icare,” adds Kämäräinen. “The rebound measurement technology is unique in character and that’s why it is patented by Icare. It is a fine example of Finnish innovation,” says Kämäräinen. Icare has been very satisfied with Etteplan’s development work and cooperation. “A new project is currently under way, and our cooperation will continue on an expanded basis.” Ari Kukkonen, R&D Director at Icare Clinical safety tests passed The Icare HOME tonometer was ready for industrial production in spring 2014, after the official trials required of medical products had been passed. “Before a product can be launched on to the market, clinical trials in which the product is compared against standard requirements and solutions already on the market are required. Safety tests required by the standards are also performed on the product,” explains Icare R&D Director Kukkonen. According to Kukkonen, elevated intraocular pressure may be a sign of glaucoma, a disease that damages the optic nerve. It should also be borne in mind that the intraocular pressure varies in different situations. For this reason, it is important that the ophthalmologist obtains reliable results over a longer period and is able on this basis to determine more precisely the right treatment.
VTT and Etteplan Partnership Paves the Way for Finnish MedTech Innovation VTT is one of Europe’s leading science and technology organization. We are owned by the Finnish state. We advance the utilisation and commercialisation of research and technology in commerce and society. Through scientific and technological means, we turn large global challenges into sustainable growth for businesses and society. We bring together people, business, science and technology to solve the biggest challenges of our time.
Balancing the energy grid with Fortum Spring Fortum is a European energy company with activities in more than 40 countries. Fortum provides their customers with electricity, gas, heating and cooling as well as smart solutions to improve resource efficiency. Fortum wants to engage their customers and society to join the change for a cleaner world. Fortum is the third largest producer of CO2-free electricity in Europe. With approximately 19,000 professionals and a combined balance sheet of approximately EUR 69 billion, Fortum has the scale, competence and resources to grow and to drive the energy transition forward.
Development of precise positioning accelerates Kalmar’s research project – Etteplan Rugged Evaluation Platform in action Kalmar offers the widest range of cargo handling solutions and services to ports, terminals, distribution centers, and to heavy industry. Kalmar is the industry forerunner in terminal automation and in energy-efficient container handling, with one in four container movements around the globe being handled by a Kalmar solution.
Supporting Johnson & Johnson in fighting intestinal parasites 2019, Johnson & Johnson announced that it is extending through 2025 global product donations of an intestinal worms treatment. The new five-year expanded commitment will ensure that one billion doses of VERMOX® CHEWABLE are provided in the 2021-2025 period to high-burden countries via donations to the World Health Organization (WHO), which manages and coordinates country requests for this valuable medicine. medical technology
Etteplan develops a remote monitoring app as an integral part of a Digital Therapeutics (DTx) solution with Orla DTx Orla DTx’s mission is to become one of the leading digital therapeutics developers. The company develops Digital Therapeutic solutions to treat serious disease together with their partners in Pharma, Diagnostics and MedTech. medical technology
